GOLDMAN SACHS GROUP INC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$18,342
+25.9%
19,106
-1.6%
0.00%
Q1 2023$14,570
+205.8%
19,426
+50.2%
0.00%
Q4 2022$4,765
-87.1%
12,931
-84.8%
0.00%
Q3 2022$37,000
-82.8%
84,825
-69.3%
0.00%
Q2 2022$215,000
-32.8%
276,163
+11.3%
0.00%
Q1 2022$320,000
-91.4%
248,071
-91.5%
0.00%
-100.0%
Q4 2021$3,705,000
+326.8%
2,916,719
+632.0%
0.00%
Q3 2021$868,000
-41.2%
398,432
+1.2%
0.00%
Q2 2021$1,476,000
+5.1%
393,644
-8.7%
0.00%
Q1 2021$1,405,000
-42.5%
431,090
-39.9%
0.00%
-100.0%
Q4 2020$2,445,000
-17.5%
717,003
-1.3%
0.00%0.0%
Q3 2020$2,964,000
+3.1%
726,445
-14.6%
0.00%0.0%
Q2 2020$2,874,000
+11.4%
850,303
-23.2%
0.00%0.0%
Q1 2020$2,580,000
-0.8%
1,107,340
+54.9%
0.00%0.0%
Q4 2019$2,601,000
-25.3%
714,721
+70.4%
0.00%0.0%
Q3 2019$3,480,000
-15.4%
419,525
-12.2%
0.00%0.0%
Q2 2019$4,115,000
-44.1%
477,963
-30.5%
0.00%
-50.0%
Q1 2019$7,356,000
+10.8%
688,118
-9.3%
0.00%0.0%
Q4 2018$6,638,000
-35.0%
758,663
+24.9%
0.00%
-33.3%
Q3 2018$10,205,000
-19.4%
607,412
+0.5%
0.00%
-25.0%
Q2 2018$12,668,000
-59.5%
604,401
-68.9%
0.00%
-50.0%
Q1 2018$31,242,000
-11.2%
1,941,739
+4.5%
0.01%0.0%
Q4 2017$35,202,000
+37.8%
1,857,580
+2.3%
0.01%
+33.3%
Q3 2017$25,537,000
+172.7%
1,814,951
+44.4%
0.01%
+200.0%
Q2 2017$9,364,000
-11.5%
1,256,958
-22.8%
0.00%
-33.3%
Q1 2017$10,576,000
+38.0%
1,627,144
-5.9%
0.00%
+50.0%
Q4 2016$7,663,000
-0.2%
1,729,833
+5.2%
0.00%0.0%
Q3 2016$7,682,000
-25.4%
1,645,043
+5.0%
0.00%
-33.3%
Q2 2016$10,296,000
+11.0%
1,567,195
+7.5%
0.00%0.0%
Q1 2016$9,272,000
+12.5%
1,457,857
+6.7%
0.00%0.0%
Q4 2015$8,239,000
+1.9%
1,366,410
+1.0%
0.00%0.0%
Q3 2015$8,088,000
-25.8%
1,352,521
-15.1%
0.00%0.0%
Q2 2015$10,902,000
+2.4%
1,593,884
-9.1%
0.00%0.0%
Q1 2015$10,643,000
+20.0%
1,753,423
+37.1%
0.00%0.0%
Q4 2014$8,866,000
-14.8%
1,279,393
+0.1%
0.00%0.0%
Q3 2014$10,408,000
+4.6%
1,278,584
+4.5%
0.00%0.0%
Q2 2014$9,946,000
-8.4%
1,223,321
-11.7%
0.00%
-25.0%
Q1 2014$10,864,000
-7.5%
1,385,773
+4.4%
0.00%0.0%
Q4 2013$11,749,000
+10.3%
1,327,560
+4.4%
0.00%0.0%
Q3 2013$10,655,000
+10.8%
1,271,510
-1.3%
0.00%0.0%
Q2 2013$9,613,000
-70.3%
1,288,602
-55.5%
0.00%
-71.4%
Q4 2012$32,394,000
+0.4%
2,895,980
+5.0%
0.01%
+7.7%
Q3 2012$32,268,000
-51.8%
2,757,987
-35.9%
0.01%
-55.2%
Q2 2012$66,916,000
+534.6%
4,300,493
+415.1%
0.03%
+480.0%
Q1 2012$10,545,000834,9510.01%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders